EMAIL THIS PAGE TO A FRIEND

PLoS ONE

Target modulation by a kinase inhibitor engineered to induce a tandem blockade of the epidermal growth factor receptor (EGFR) and c-Src: the concept of type III combi-targeting.


PMID 25658745

Abstract

We're sorry this abstract is currently not available.